Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPAL-HK: Patiromer in CKD with Hyperkalemia
NCT01810939Phase 3Completed
- Sponsor
- Relypsa, Inc.
- Start
- Feb 2013
- Primary completion
- Jul 2013
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of patiromer in hyperkalemia, sponsored by Relypsa, Inc.. Started Feb 2013; status: completed.
02
Drugs
patiromer
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT01810939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01810939.